Providence and Humana launched a new initiative to standardize and streamline data exchange between payers and providers. The program leverages FHIR-based APIs to create a scalable, real-time system that can be replicated across other healthcare organizations nationwide.
Providence and Humana launched a new initiative to standardize and streamline data exchange between payers and providers. The program leverages FHIR-based APIs to create a scalable, real-time system that can be replicated across other healthcare organizations nationwide.
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone. Learn More.
Knownwell's $25 million in funding was led by CVS Health Ventures and included participation from MassMutual Catalyst Fund, Intermountain Ventures, a16z Bio + Health and Flare Capital Partners.
Roche's Gazyva, which first reached the market as a blood cancer drug, has expanded its FDA approval to include treatment of the autoimmune disorder lupus nephritis. The CD20-targeting antibody can now compete against a blockbuster GSK drug that is the standard biologic therapy for the debilitating kidney condition.
The way forward isn't bigger models. It's smaller, smarter ones. Small Language Models (SLMs) are designed to do what LLMs can't: learn from enterprise data and focus on specific problems.
To Chirag Shah, the success of a healthcare AI startup often depends on its ability to move beyond a narrow point solution. He believes it is essential to integrate AI into workflows and expand from initial "wedges" into full platforms.
In this episode, a pharmacy benefit management executive and a pharmacy startup talk about why benefit verification, prior authorizations, and patient affordability still break the workflow and how smart integrations, real-time eligibility, and intuitive design can reduce friction for all involved.
No comments